Cardiac, Metabolic Morbidity Highly Prevalent in Patients With Alopecia Areata
The largest study examining the relationship between alopecia areata and cardiovascular disease in a US cohort is reviewed.
Metabolic
Metabolic Syndrome Linked to Worse Outcomes in COVID-19
Metabolic syndrome (MetS) is associated with a lethal outcome for patients with COVID-19.
Evidence Appears to Support Link Between Rosacea and Cardiometabolic Syndrome
Hypertension, dyslipidemia, and obesity were among the conditions investigators reviewed as being affected by the underlying inflammation associated with rosacea.
Prevalence of Metabolic Syndrome on the Rise for Some Patient Populations
The prevalence of metabolic syndrome is rising at an unequal rate among different patient demographics.
Skeletal Muscle Disease and Cardiometabolic Dysfunction in Rheumatoid Arthritis
Skeletal muscle alterations in rheumatoid arthritis are often overlooked despite their important role in disability and cardiometabolic disease development.
Metabolic Syndrome on the Rise Among Young Adults in the United States
The prevalence of metabolic syndrome among young adults in the United States is rising.
Unique Metabolic Signature Predicts Transition to T2D After Gestational Diabetes
Amino acid dysmetabolism can be detected during the early postpartum period and is predictive of the transition from gestational diabetes to type 2 diabetes.
Suboptimal Cardiometabolic Screening Rates for Patients With Psoriasis, Hidradenitis Suppurativa, and Atopic Dermatitis
Despite their known associations, patients with psoriasis, hidradenitis suppurativa, and atopic dermatitis are not often screened for cardiometabolic comorbidities.
How Does Gender-Affirming Hormone Treatment Affect the Metabolic Profile in Transgender Individuals?
Cross-sex hormone therapy may have a negative effect on lipid profile and glucose levels in transgender men but not in transgender women.
Apremilast Improves Psoriatic Disease and Cardiometabolic Markers
A novel study assesses the safety and efficacy of apremilast in patients with psoriasis and evaluates the treatment as a metabolic modulator.
-
Loading...
-
Loading...
